Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2025

Genmab — Januar 2025

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #108

    4,5 years without any information about this part of the deal - so guess they have not done anything at all. Which of them to blame?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #109

      my guess is that a 50:50 collaboration is too expensive for a company like Abbvie, unless they get offered an antibody that really knocks it out of the park...

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #110

        i had hopes for a duohexabody or hexelect, but alas... not expecting much anymore , besides possibly another disease area with Epco

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #111

          the other side is offcourse also; IF Genmab has a great idea; do they still want to share it... or try to develop it themselves...

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #112

            https://www.linkedin.com/posts/janvandewinkel_innovation-antibodyscience-jpm2025-activity-7284646692912562179-Dgdb?utm_source=share&utm_medium=member_ios Winkel

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bikube
              wrote on sidst redigeret af
              #113

              JnJ har udsendt Transcript fra J P Morgans Healthcare Conference, den ligger på Seeking Alfa. Er der ikke noget fra Genmab endnu ?

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #114

                JNJ have the transcript also on their website https://s203.q4cdn.com/636242992/files/doc_downloads/2024/09/jnj-usq_transcript_2024-09-04.pdf

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #115

                  Genmab will present tonight

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #116

                    sry that was the Morgan Stanley conference for JNJ 🙂 , JPM not there yet. need stronger coffee...

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #117

                      Xian Deng
                      UBS Buy Kr.2,700.00 Maintained 13-1-25

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Stroka
                        wrote on sidst redigeret af
                        #118

                        Sikken en sjælden kursfest vi har i aktien lige nu 🙂

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #119

                          Genmab-aktien rummer potentiale på 40 pct. ifølge Handelsbanken https://proinvestor.com/investornyt/1264955/genmab-aktien-rummer-potentiale-pa-40-pct-ifolge-handelsbanken

                          1 Reply Last reply
                          0
                          • exitnuE Offline
                            exitnuE Offline
                            exitnu
                            wrote on sidst redigeret af
                            #120

                            43rd Annual J.P. Morgan Healthcare Conference. Spændende, men lidt sent dansk tid: 15. januar 2025 fra 00:00 til 00:40:

                            https://jpmorgan.metameetings.net/events/healthcare25/sessions/58157-genmab-a-s/webcast?gpu_only=true&kiosk=true

                            (Link to webcast)

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #121

                              Vi tager gerne en lille forfest med Stroka;-)

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                Bullish
                                wrote on sidst redigeret af
                                #122

                                Det var alligevel meget: Jeg spurgte om vi havde nået bunden 17. december, og købte i kurs 1.411. Jeg skulle vist bare ha' powershoppet! Men det er da også et helt uforståeligt fald der er sket
                                .

                                1 Reply Last reply
                                0
                                • V Offline
                                  V Offline
                                  Vitus
                                  wrote on sidst redigeret af
                                  #123

                                  Desværre har fester med at stoppe, når det går allerbedst 🙂

                                  1 Reply Last reply
                                  0
                                  • D Offline
                                    D Offline
                                    deleted-user
                                    wrote on sidst redigeret af
                                    #124

                                    vitus - har du en meget kort investeringshorisont? 🙂

                                    1 Reply Last reply
                                    0
                                    • V Offline
                                      V Offline
                                      Vitus
                                      wrote on sidst redigeret af
                                      #125

                                      Nej, jeg har været med i Genmab siden 2011, så det vil jeg ikke sige…

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #126

                                        Lidt konkurrence til Tepezza

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #127

                                          https://www.fiercebiotech.com/biotech/slings-oral-tepezza-rival-hits-goal-thyroid-eye-disease-setting-stage-confirmatory-phase-3

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper